Showing results (2971-2980 of 6,517) with videos related to
Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|June 21, 2012
Harmonization of the intracellular cytokine staining assayMarij J P Welters, Cécile Gouttefangeas, Tamara H Ramwadhdoebe, et al.Cancer Immunology, Immunotherapy : CII|June 19, 2012
DNA and adenovirus tumor vaccine expressing truncated survivin generates specific immune responses and anti-tumor effects in a murine melanoma modelHaihong Zhang, Yuqian Wang, Chenlu Liu, et al.Cancer Immunology, Immunotherapy : CII|September 4, 2012
ADAM17-overexpressing breast cancer cells selectively targeted by antibody-toxin conjugatesAhmad Trad, Hinrich P Hansen, Mohammad Shomali, et al.Cancer Immunology, Immunotherapy : CII|September 4, 2012
Concomitant combination of active immunotherapy and carboplatin- or paclitaxel-based chemotherapy improves anti-tumor responseY Diaz, Y Tundidor, A Lopez, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1990
Enhanced resistance against Escherichia coli infection by subcutaneous administration of the hot-water extract of Chlorella vulgaris in cyclophosphamide-treated miceF Konishi, K Tanaka, S Kumamoto, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1990
Opposing influence of age on the growth and colony-forming ability of mouse melanoma B16 and mammary adenocarcinoma: correlation with natural killer activityJ Gabrilovac, M Radacić, M Osmak, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1990
Selective restoration of immunosuppressive effect of cytotoxic agents by thymopoietin fragmentsL Dénes, B Szende, G Hajós, et al.Cancer Immunology, Immunotherapy : CII|October 2, 1998
Immunization with a tumor-cell-lysate-loaded autologous-antigen-presenting-cell-based vaccine in melanomaN G Chakraborty, J R Sporn, A F Tortora, et al.Cancer Immunology, Immunotherapy : CII|October 2, 1998
Human tumor cells, modified by a novel pressure/crosslinking methodology, promote autologous lymphocyte proliferation and modulate cytokine secretionA Eisenthal, Y Goldman, Y Skornick, et al.Cancer Immunology, Immunotherapy : CII|October 2, 1998
Transcription factor activation in lymphokine activated killer cells and lymphocytes from patients receiving IL-2 immunotherapyC M Nicolet, J M Surfus, J A Hank, et al.Pageof 652